Given all the talk about the pandemic, the delta variant and everything else, it would be easy to believe that pharmaceutical stocks are doing well this year. But the fact is, according to the benchmark S&P Pharmaceuticals Select Industry Index, the sector is down almost 9% year-to-date. That compares to a solid 17% return for…

Investors in the biopharma space have seen some outsized volatility of late. For investors in Clearside Biomedical (NASDAQ:CLSD) and CLSD stock, the good news is that most of this volatility has been to the upside. Currently, CLSD stock is up more than 45% on extremely heavy volume. Source: Shutterstock Clearside is a biopharmaceutical company focused on developing…